Aspen Pharmacare Holdings Limited (FRA:LDZA)

Germany flag Germany · Delayed Price · Currency is EUR
5.80
-0.05 (-0.85%)
At close: Jan 9, 2026
-33.71%
Market Cap2.72B
Revenue (ttm)2.08B
Net Income (ttm)-51.93M
Shares Outn/a
EPS (ttm)-0.12
PE Ration/a
Forward PE9.39
Dividend0.10 (1.80%)
Ex-Dividend DateOct 1, 2025
Volumen/a
Average Volume133
Open5.80
Previous Close5.85
Day's Range5.80 - 5.80
52-Week Range4.50 - 9.30
Betan/a
RSI71.96
Earnings DateFeb 27, 2026

About Aspen Pharmacare Holdings

Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and markets specialty and branded pharmaceutical products in Africa, the Middle East, the Americas, Europe CIS, Australasia, and Asia. It operates through Commercial Pharmaceuticals and Manufacturing segments. The company offers injectables for therapeutic areas, such as anaesthetics, anticoagulants, antithrombotic agents, analgesics, and hormone replacement medicines under the Arixtra, Diprivan, Fraxiparine, Marcaine, Sustanon, and Xylocaine brands; over-the-counte... [Read more]

Industry Pharmaceutical Preparations
Founded 1850
Employees 9,557
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol LDZA
Full Company Profile

Financial Performance

Financial numbers in ZAR Financial Statements

News

There is no news available yet.